List of Abbreviations
LBP – low back pain
VAS – visual analogue scale (for pain)
HIV – human immunodeficiency virus
GC – glucocorticoids
LSR – lumbosacral radiculopathy
GIT - gastrointestinal tract
IL – interleukins
ICD-10 – International Classification of Diseases, 10th Revision
MRI – magnetic resonance imaging
NSAIDs – non-steroidal anti-inflammatory and antirheumatic drugs
PET – positron emission tomography
CT – computed tomography
SN – spinal nerve
US – ultrasound examination
LCE – level of confidence of evidence
GRS – grade of recommendation strength
TNF – tumor necrosis factor
NRS – numerical rating scale (for pain)
ENMG – electroneuromyography
EMG – electromyography
Terms and Definitions
Discogenic lumbosacral radiculopathy (DSR) is damage to the lumbar or first sacral spinal nerve (SN) roots due to their compression by intervertebral disc components, manifested by pain and/or sensory disturbances in the corresponding dermatomes, weakness in the corresponding myotomes (indicator muscles), and reduction or loss of the knee or Achilles reflexes. DSR lasting up to 4 weeks is considered acute, from 5 to 12 weeks – subacute, and after 12 weeks – chronic.
In addition to disc herniation, there are other causes of nerve root compression in radiculopathy, such as ligamentum flavum hypertrophy, osteophyte formation, facet joint hypertrophy, foraminal stenosis, and spondylolisthesis. Root damage can be associated with neoplasms – root neurinomas, primary and metastatic vertebral tumors, meningeal carcinomatosis; congenital anomalies – arteriovenous malformations, arachnoid and synovial cysts; infections – osteomyelitis, epidural abscess, tuberculosis, herpes zoster, Lyme disease, HIV infection; inflammatory diseases – sarcoidosis, vasculitis; endocrine and metabolic disorders – diabetes mellitus, Paget's disease, acromegaly. However, these causes, excluding degenerative-dystrophic changes of the spine, collectively account for less than 1% of radiculopathy cases and are not covered in these guidelines.
Lumbosacral pain (sciatica) is a pain syndrome in the lumbar region radiating to the leg. This term primarily refers to non-specific musculoskeletal pain syndromes, i.e., conditions where the sources of pain may be muscles, joints, and ligaments, but not the spinal nerve roots.
Intervertebral disc protrusion is displacement of disc fragments involving less than 25% of the circumference, with the length of the displaced fragment being less than the width of its base.
Intervertebral disc extrusion is displacement of disc fragments where the size of the displaced fragment in any plane exceeds the size of the base. Sequestration is a subtype of extrusion in which the displaced disc fragment loses continuity with the base.
1. Brief information on the disease or condition
1.1 Definition of the disease or condition
Discogenic lumbosacral radiculopathy (DSR) is damage to the lumbar or first sacral spinal nerve (SN) roots due to their compression by intervertebral disc components (protrusion, extrusion), manifested by pain and/or sensory disturbances in the corresponding dermatomes, weakness in the corresponding myotomes (indicator muscles), and reduction or loss of the knee or Achilles reflexes [1-9].
1.2 Etiology and pathogenesis of the disease or condition (group of diseases or conditions)
DSR is caused by intervertebral disc protrusion or extrusion (herniation). Disc herniation development is driven by a combination of age-related progressive degenerative changes in spinal structures, connective tissue characteristics, and physical stressors (e.g., heavy physical labor, non-physiological working postures, prolonged static loads, sudden uncoordinated movements) [6-8,10-14]. Heavy physical labor, obesity, and smoking play an important role in the onset of the first episode of radiculopathy [15]. Intervertebral disc herniations on magnetic resonance imaging (MRI) or computed tomography (CT) are conveniently described according to the classification [10], which distinguishes disc protrusion (bilateral size of the herniated fragment's base is larger than the bilateral size at the apex), disc extrusion (rupture of the annulus fibrosus, bilateral size of the herniated fragment's base is smaller than any of the herniated fragment's dimensions), and sequestration (the herniated fragment is located separately from the disc).
Intervertebral disc herniations are common in elderly, middle-aged, and even young individuals. Intervertebral disc herniations may be asymptomatic (without back pain or other symptoms); therefore, their detection on spine MRI or CT in a patient with back pain does not mean they are the cause of it [1,3,4,7,8].
In the pathogenesis of DSR, besides compression-ischemia-induced SN damage, local inflammatory and autoimmune reactions play an important role. Annulus fibrosus rupture brings the nucleus pulposus into contact with the immune system, which perceives it as a foreign body, triggering autoimmune reactions with B-lymphocyte activation and autoantibody production, as well as cytotoxic T-lymphocytes. This in turn causes a complex cascade of immunological reactions with the release of large amounts of cytokines (IL-1α, IL-1β, IL-6, IL-8, prostaglandin E2, and TNF-α) that sustain inflammation and contribute to pain [6,16]. The immunological mechanism also underlies the natural reduction of disc herniation over time; resorption of herniated fragments occurs over several months via biochemical degradation of connective tissue components and phagocytosis [6,16]. The regression of inflammatory changes outpaces the reduction in disc herniation size, and pain and other neurological deficits resolve before the disc herniation is seen to regress [17]. Pain in DSR is mixed in nature—being both nociceptive and neuropathic [18].
1.3 Epidemiology of the Disease or Condition
According to various sources, the prevalence of DSR ranges from 1.6% to 13.4%, peaking at 45–64 years of age, and is more common in men than in women. Among patients with back pain presenting to general practitioners, this diagnosis is established in 2–11% of cases [19,20].
The prevalence of disc herniations is high in the general population, including asymptomatic cases; therefore, a comprehensive clinical and neuroimaging assessment of the patient's condition is essential [9].
1.4 Features of Coding the Disease or Condition
M51.1 – Lumbar and other intervertebral disc disorders with radiculopathy
G55.1* – Nerve root and plexus compressions in disorders of intervertebral discs (* not to be used as a primary code)
1.5 Classification of the disease or condition
DSR is classified as acute (up to 4 weeks), subacute (from 4 to 12 weeks), and chronic (after 12 weeks) [9,21,22].
1.6 Clinical presentation of the disease or condition
DSR is characterized by acute shooting pain in the lower back and leg, often triggered by significant physical exertion, such as lifting heavy objects. It frequently worsens with coughing, sneezing, and forward bending, and eases in the recumbent position [1,3,4,7,8,18,23]. The fifth lumbar and first sacral roots are most commonly affected (up to 90% of cases), followed less frequently by the fourth lumbar root, and very rarely by the upper lumbar roots [1,3,4,7]. Lesions of the 5th lumbar or 1st sacral root typically radiate below the knee into the foot and toes, while 4th root lesions radiate along the anterior and lateral thigh [8,24].
Main clinical manifestations of DSR: 1) lower back pain radiating to the leg; 2) sensory disturbances in the corresponding dermatomes; 3) weakness in the corresponding myotomes (indicator muscles); 4) diminished or absent knee or Achilles reflexes; 5) positive nerve root tension signs [1,3,4,7,8,18,23,24]. Clinical manifestations of root lesions at various levels are presented in Appendix G1. Typically, neuropathic pain syndrome predominates, characterized by intense acute shooting or, less commonly, burning pain, paresthesias, and other sensory impairments radiating to the distal dermatome.
The clinical course of DSR is favorable; approximately half of patients improve within 4–12 weeks, and the majority (55–70%) of patients experience a gradual resolution of symptoms within a year [25–27]. Spontaneous partial regression of a sequestered disc herniation is observed in 96% of cases, extrusion in 70%, disc protrusion in 41%, and complete regression of a sequestered herniation in nearly half (43%) of observations [17]. Repeat MRI studies over the course of a year show more than a twofold reduction in size for approximately 60–70% of intervertebral disc herniations [28].
2. Diagnostics, medical indications and contraindications for diagnostic methods
Criteria for establishing the diagnosis. Diagnostics of lumbar disc radiculopathy (LDR) is indicated for all patients with suspected LDR. The diagnosis of LDR is established based on the collection of complaints and anamnesis of the disease; a brief somatic examination to rule out "specific causes"; a neurological examination (extent of pain and hypesthesia, reflex changes, presence of muscle atrophy, limb paresis; the results of neurodynamic tests are of great importance). Neuroimaging results are not independently significant in diagnostics and must be correlated with the clinical picture of the disease. Clinical diagnostic methods for LDR are detailed in Appendices G1-G4.
2.1 Complaints and Anamnesis
When collecting complaints and anamnesis in patients with suspected LDR, it is recommended to use a brief questionnaire to identify signs of so-called "specific" causes of the disease in order to choose further management tactics for the patient (Table 1) (Level of Evidence – 5, Grade of Recommendation – C) [29-32].
Table 1. Red flags for back pain.
Age | Younger than 18 years and older than 50 years |
Anamnesis | Presence of recent back trauma; Presence of a malignant neoplasm (even in cases of radical tumor removal); Prolonged glucocorticoid (GC) use; Drug addiction; HIV infection; Immunocompromised state; Periodically occurring malaise; Unexplained weight loss |
Nature and localization of pain | Constantly progressive pain that is not relieved at rest ("non-mechanical" pain); Chest pain; Unusual localization of pain: in the perineum, rectum, abdomen, vagina; Association of pain with defecation, urination, sexual intercourse |
If a patient with suspected LDR presents with red flags, an additional examination of the patient (somatic and neurological examination, neuroimaging) is recommended (Level of Evidence – 5, Grade of Recommendation – C) [6-8,19,23,33] to search for specific causes of the disease.
To assess the severity of the condition and treatment efficacy in patients with LDR, it is recommended to evaluate pain intensity both at the time of presentation and dynamically (Level of Evidence – 3, Grade of Recommendation – B). Standardized scales can be used for this: visual analogue scale (VAS), numerical rating scale (NRS), verbal rating scale (VRS) [34,35] (Appendix G2).
2.2 Physical Examination
A somatic examination of patients with suspected LDR is recommended to rule out specific causes of back pain; it aims to detect signs of spinal fractures, malignant neoplasms, infectious processes, and other somatic conditions that may present with back pain, and includes checking for fever, weight loss, skin changes, lung auscultation, abdominal and lymph node palpation (Level of Evidence – 5, Grade of Recommendation – C) [3,8,9,21,22,26,33]. If signs of a specific disease are detected, additional examinations are recommended (Table 2).
Table 2. Some red flags, their possible causes, and recommended medical tactics in patients with back pain
Red flags | Possible causes of pain | Medical tactics |
|---|---|---|
History of malignant neoplasm; unexplained weight loss; age over 50 years; onset or worsening of pain at rest, at night | Malignant neoplasm | MRI or CT of the spine (one segment), in some cases – whole-body bone scintigraphy, whole-body PET-CT of bones, consultation with an oncologist |
Fever, recent infectious disease, parenteral drug use | Infectious involvement of vertebrae or discs | Radiography of the lumbosacral spine, spine radiography with functional tests, MRI or CT of the spine (one segment), consultation with a phthisiatrician, infectious disease physician |
Pelvic disorders, limb paresis, perineal anesthesia | Cauda equina syndrome | MRI or CT of the spine (one segment), urgent neurosurgeon consultation |
Presence of signs of osteoporosis, GC use, age over 50 years, recent back trauma | Vertebral compression fracture | Radiography of the lumbar and sacral spine, spine radiography with functional tests, MRI or CT of the spine (one segment), ultrasound densitometry, lumbar spine X-ray densitometry, rheumatologist consultation |
Morning stiffness, young age, waking up in the second half of the night due to pain, improvement after exercise while taking NSAIDs | Ankylosing spondylitis (Bekhterev's disease) | Radiography of the lumbosacral spine, spine radiography with functional tests, rheumatologist consultation |
Presence of a pulsating mass in the abdominal cavity | Abdominal aortic aneurysm | Complex ultrasound of abdominal organs. CT of abdominal organs, surgeon consultation |
Pronounced or progressive leg weakness | Lumbar stenosis | MRI or CT of the spine (one segment), neurosurgeon consultation |
Clinical examination with neurological status assessment is the basis of LDR diagnostics (Appendices G3, G4). For clinical evaluation, a comprehensive examination is recommended, including analysis of pain localization and character, detection of paresis and sensory disorders, evaluation of knee or Achilles reflexes, testing for tension signs (sitting or supine straight leg raise test, straight and crossed Lasègue signs), as well as exclusion of specific causes of pain (Level of Evidence – 5, Grade of Recommendation – C) [3,7,8,21-23,33].
Establishing the diagnosis of LDR is recommended based on a triad: 1) Based on complaints, anamnesis, and examination (Tables 1, 2), no red flags regarding specific causes of back pain were identified; 2) Clinical examination with neurological status assessment revealed signs of LDR, positive tension tests; 3) Neuroimaging results (if available) directly correlate with the clinical picture (disc herniation localization corresponds to pain radiation zones and sensory disorder distribution, weakness in "indicator" muscles, loss of corresponding reflexes (Appendix G1). (Level of Evidence – 5, Grade of Recommendation – C) [3,7,8,23,33,36].
To assess the severity of impaired functions, disease dynamics, and the effectiveness of ongoing treatment in LDR, the use of the Oswestry or Roland-Morris questionnaires is recommended (Appendices G5 and G6) (Level of Evidence – 3, Grade of Recommendation – B) [37].
Comments. In some cases, manifestations similar to LDR are observed in foraminal (lateral lumbar) stenosis caused by a cyst or other causes of lumbar spinal nerve compression, or in piriformis syndrome with sciatic nerve compression [8,24,36]. Piriformis syndrome is determined based on its palpation, regression of pain and other symptoms after local anesthetic administration into the muscle; foraminal stenosis is determined based on clinical data and MRI [8,24,36].
2.3 Laboratory Diagnostics
In LDR, there are no changes associated with this condition in the complete blood count, general general-health biochemical blood test, urinalysis, as well as in other laboratory tests.
Laboratory tests are not recommended in LDR unless there are signs of a specific cause of non-specific low back pain (spinal fracture, infectious, systemic inflammatory, oncological, or other disease) [10-11] (Level of Evidence – 5, Grade of Recommendation – C).
2.4 Instrumental Diagnostics
Patients with manifestations of LDR are recommended to undergo magnetic resonance imaging of the spine (one segment) in the presence of red flags (Level of Evidence – 5, Grade of Recommendation – C), as MRI makes it possible to rule out specific causes of pain (tumor, fracture, etc.) and other neurological diseases [1,3,7,21-23,36].
If MRI is contraindicated, computed tomography of the spine (one segment) or CT myelography (computed tomography of the spine with intravenous contrast (one segment)) is recommended to rule out a specific disease (Level of Evidence – 5, Grade of Recommendation – C) [1,3,7,21-23,36].
Emergency MRI or CT of the spine (one segment), CT of the spine with intravenous contrast (one segment) is recommended upon detection of cauda equina syndrome (pelvic organ dysfunction, loss of perineal sensation, progressive paresis of both legs) to determine further treatment tactics (Level of Evidence – 5, Grade of Recommendation – C) [1,3,7,21-23,36]. In the absence of red flags and a typical clinical picture, performing MRI, CT (one segment), or radiography of the lumbosacral spine within the first 4 weeks is not recommended (Level of Evidence – 2, Grade of Recommendation – A), because there is no evidence of the necessity for early (up to 4 weeks) spine imaging [8,9]. MRI, CT, and radiography do not improve disease outcomes in patients with LDR [38-40].
If there is no improvement in condition (regression of pain and other neurological disorders) within 4–6 weeks, MRI or CT of the lumbosacral spine (one region) is recommended to rule out a specific cause of the disease and to refer the patient for a neurosurgical consultation if a clinically significant disc herniation is detected (Level of Evidence – 5, Grade of Recommendation - C) [40-42].
MRI or CT of the spine (one region) is recommended at an early stage (within 4 weeks) if: 1) the patient has progressive neurological deficits or persists with severe pain despite therapy, in order to rule out a specific disease; 2) epidural administration of GCs and local anesthetics is planned, in order to determine the size and localization of the disc herniation and the level of intervention (Level of Evidence – 5, Grade of Recommendation - C) [40-42].
Comments. Since MRI does not involve ionizing radiation and is informative in detecting disc herniations, its use is preferred over CT and CT myelography. When ordering CT and CT myelography, the radiation dose should be taken into account.
2.5 Other Procedures
Instrumental diagnostic methods (needle electromyography (ENMG) of one nerve, stimulation electroneuromyography of one nerve, needle electromyography (EMG) of one muscle, surface electromyography of one anatomical zone, registration of somatosensory evoked potentials of motor nerves (SSEP)) are recommended only in patients with an unclear clinical picture of lumbosacral radiculopathy, to rule out spinal cord lesions and other diseases of the peripheral nervous system (Level of Evidence – 5, Grade of Recommendation - C) [1,6,7].
Comments. ENMG investigates the conduction velocity of excitation along motor and sensory fibers of peripheral nerves, the amplitudes of motor and sensory responses, and their latencies. If ENMG reveals signs indicative of peripheral nerve pathology, additional electrodiagnostic studies, such as EMG, should be considered. Needle EMG of the muscles of affected myotomes may reveal spontaneous activity (signs of denervation) and reinnervation changes in motor unit action potentials. The somatosensory evoked potential method in this case can be useful for ruling out a spinal level of sensory impairment.
In chronic lumbosacral radiculopathy, assessment of psychological and social pain factors is recommended (Level of Evidence – 5, Grade of Recommendation - C), because their presence helps refine the prognosis of the disease and enables the use of effective psychological therapy methods [3,43,44].
Comments. In clinical practice, psychological and social aspects are evaluated relatively rarely. The assessment of psychological and social factors is carried out primarily in specialized pain treatment centers.
3. Treatment, including drug and non-drug therapies, diet therapy, and pain management
Introduction to the section. In each case of acute lumbosacral radiculopathy, it is necessary to determine which treatment strategy to prefer: surgical or conservative methods. Emergency surgical treatment is recommended only in the presence of absolute indications (see the surgical treatment section). In all other cases, the dynamics of changes should be assessed over a period of 6 to 12 weeks of the disease, and only then should the issue of the advisability of surgical intervention be decided. Conservative treatment of lumbosacral radiculopathy involves a comprehensive approach including pharmacotherapy, non-pharmacological methods of intervention, and in some cases (mainly in the acute and subacute periods) epidural GC injections (see other treatment methods section). Physiotherapy, manual therapy, reflexology for diseases of the peripheral nervous system, massage, and other non-pharmacological methods do not have major independent significance in the treatment of lumbosacral radiculopathy, but are components of a comprehensive treatment program.
3.1 Conservative Treatment
3.1.1 Non-pharmacological treatment
It is recommended to inform the patient about the benign nature of the disease, the likelihood of gradual improvement within 4–6 weeks, the possibility of spontaneous regression of the disc herniation, the advisability of maintaining tolerable physical, social, and professional activity, and avoiding prolonged bed rest (Level of Evidence – 2, Grade of Recommendation - B), because this improves the natural course of the disease [9,19,25,45,46].
In cases where patients are forced to observe bed rest due to intense pain, its duration should not exceed 3–5 days. Longer bed rest worsens the course of the disease [47]. It is advisable to explain to the patient that they may observe brief bed rest during intense pain, but this is a way to reduce pain, not a method of treatment [47].
Comments. Informing the patient about a favorable prognosis of discogenic radiculopathy and maintaining physical activity prevents catastrophizing the subjective perception of the disease and promotes recovery. A prolonged decrease in professional, social, and daily activity worsens the prognosis and course of the disease.
Therapeutic physical exercise for diseases of the peripheral nervous system is recommended for patients with discogenic radiculopathy when pain subsides (LEL – 1, GRD - A), because it can reduce pain and improve the functional state of patients [45,48,49]. No advantages of a specific type of exercise have been noted; its implementation requires supervision by a specialist, and the load must be adequate to the patient's condition [45,48,49]. Maintaining physical activity reliably promotes recovery and positively affects the general condition of patients [50].
Comments. Therapeutic physical exercise is a complex of dynamic and/or static exercises, including aerobic loads, methods of static and dynamic muscle strengthening, mobilization exercises, as well as general conditioning exercises. Therapeutic physical exercise has a positive effect on the general health of patients, preventing recurring episodes of pain, and is devoid of serious side effects if performed under the supervision of a specialist, taking into account the functional capabilities of the patient.
Manual therapy for diseases of the peripheral nervous system is recommended for patients with subacute and chronic discogenic radiculopathy (LEL – 1, GRD - A), as its use can reduce pain and improve the functional state of patients [51–55]. The positive effect of manual therapy on pain and the functional state of patients has been noted compared to sham therapy in small studies [52,55]. In acute discogenic radiculopathy, manual therapy is associated with the risk of increased herniation size according to MRI data [51]. Manual therapy is recommended by US experts [41] and Danish experts [42], in combination with therapeutic physical exercise in the UK [40], but is not recommended by experts in some European countries [55].
Comments. Among manual therapy methods, soft tissue techniques are the safest; their application must take into account the patient's condition. Manual therapy can lead to increased pain and worsening of functions due to additional impact on musculoskeletal structures, but these complications are transient; serious complications (fractures, cauda equina root compression, vascular complications) are rare [51,52,55].
Psychological methods of therapy, including cognitive behavioral therapy and mindfulness therapy (clinical and psychological adaptation, clinical and psychological counseling, clinical and psychological correction, clinical and psychological training), are recommended in patients with chronic discogenic radiculopathy (LEL – 1, GRD - B), because they reduce pain and improve the functional state of patients with chronic back pain [56–60]. Psychological treatment methods must be combined with therapeutic physical exercise [40].
Comments. Psychological methods are used primarily in specialized centers for the treatment of patients with chronic back pain.
Reflexology for diseases of the peripheral nervous system is recommended in chronic discogenic radiculopathy (LEL – 1, GRD - A), because it can reduce pain and improve the functional state of patients. Reflexology is not associated with serious adverse events [53,61,62]. Reflexology is not recommended for discogenic radiculopathy by experts in some countries [40,42] due to its unproven efficacy.
Comments. Reflexology is likely effective in patients who have previously had a positive experience with its use for discogenic radiculopathy or other conditions.
Massage of the lower back and lower limb muscles (medical lower limb massage, lower limb and lower back massage, lumbosacral spine massage, medical back massage) is recommended in patients with chronic discogenic radiculopathy (LEL – 1, GRD - A); some studies have noted a decrease in pain intensity after massage [63].
Comments. Massage remains one of the most widespread methods of treating patients with back pain in our country, and many patients associate significant improvement in their condition with massage. However, it is not recommended by experts in various countries for the management of patients with degenerative lumbosacral radiculopathy due to the lack of sufficient evidence of its efficacy [40-42].
Various methods of physiotherapeutic treatment. Some studies have noted the efficacy of pulsed low-frequency electromagnetic field therapy in chronic degenerative lumbosacral radiculopathy; this method is recommended as part of combination therapy to reduce pain intensity and improve impaired functions (Evidence Level – 2, Recommendation Grade - B) [64, 65].
Traction (skeletal, underwater, and spinal traction) is not recommended for degenerative lumbosacral radiculopathy (Evidence Level – 1, Recommendation Grade - A), as no evidence of its efficacy has been obtained [45, 66].
The wearing of corsets, braces, belts, and other special orthopedic devices that immobilize the lumbosacral spine is not recommended for patients with degenerative lumbosacral radiculopathy (Evidence Level – 5, Recommendation Grade - C), as these methods do not relieve pain or improve patients' functional activity [45, 53, 127].
Comments. The wearing of corsets, braces, belts, and other special orthopedic devices and traction are also not recommended by experts from various countries for the management of patients with degenerative lumbosacral radiculopathy [40-42]. The wearing of corsets, braces, belts, and other special devices is recommended if there are indications for orthopedic correction, regardless of the presence of degenerative lumbosacral radiculopathy.
3.1.2 Pharmacotherapy
Nonsteroidal anti-inflammatory and antirheumatic drugs (NSAIDs); ATC code: M01A** (drugs with analgesic, anti-inflammatory, and antipyretic effects) are recommended for patients with acute, subacute, or acute exacerbation of degenerative lumbosacral radiculopathy (Evidence Level – 1, Recommendation Grade - A), as they are capable of reducing pain and improving the functional state of patients [67-70]. It is recommended to prescribe NSAIDs at effective doses for the minimum necessary number of days in order to reduce the risk of adverse effects [71-73]. Currently, no reliable advantage of any single NSAID over others regarding back pain relief has been established [70-73]. The use of oral NSAID formulations is preferable, as parenteral administration has no advantages in terms of efficacy but is significantly inferior in safety [72, 73]. For acute high-intensity pain, short-term use of a combination drug containing diclofenac + orphenadrine is possible [74].
Comments. The prescription of NSAIDs is the most common management strategy for patients with acute and subacute dorsalgia [9]. When choosing an NSAID, it is necessary to take into account the presence and nature of risk factors for adverse events, concomitant diseases, and drug-drug interactions. NSAIDs should not be combined with each other or used long-term (it is advisable to limit treatment to 10–14 days), which significantly reduces the risk of complications from the gastrointestinal tract, cardiovascular, and other systems. NSAIDs are contraindicated in erosive and ulcerative lesions of the gastrointestinal tract, especially in the acute phase, severe hepatic and renal impairment, individual intolerance, pregnancy, and severe heart failure. In patients at risk for gastrointestinal complications, it is recommended to use NSAIDs with the lowest risk of such complications (meloxicam, nimesulide, aceclofenac, and coxibs (M01AH) (celecoxib, etoricoxib) [75-79], at low doses and for a short duration, and/or to consider gastroprotection for the prevention of such complications [73]. When choosing a specific NSAID, it is necessary to check the package leaflet for the relevant indication and the absence of contraindications.
Antiepileptic drugs (ATC code: N03AX; gabapentin, pregabalin**) are recommended for pain reduction in degenerative lumbosacral radiculopathy (Evidence Level – 2, Recommendation Grade - B), given their positive effect on neuropathic pain. A number of studies have shown the superiority of gabapentin and pregabalin** over placebo in acute and chronic degenerative lumbosacral radiculopathy [80-84]. However, according to a systematic review, no efficacy of antiepileptic drugs was noted in this disease [85].
Antidepressants (non-selective monoamine reuptake inhibitors: amitriptyline**, ATC code: N06AA; duloxetine, ATC code: N06AX21) are recommended for patients with chronic degenerative lumbosacral radiculopathy (Evidence Level – 2, Recommendation Grade - A) because they exert an analgesic effect in chronic back pain [67, 86, 87, 118, 119, 120]. The use of antidepressants is most justified when a comorbid depressive disorder is identified.
Comments. The use of antidepressants (duloxetine and non-selective monoamine reuptake inhibitors) remains one of the possible treatment methods for chronic non-specific back pain in combination with exercise therapy. At the same time, experts in a number of countries do not recommend antidepressants for degenerative lumbosacral radiculopathy [40-42].
B vitamins (Vitamin B1 in combination with vitamins B6 and/or B12, ATC code: A11DB) are recommended for acute degenerative lumbosacral radiculopathy in combination with NSAIDs to reduce pain (Evidence Level – 2, Recommendation Grade - B), because the addition of B vitamins to NSAIDs may provide an additional analgesic effect [88-91].
Comments. B vitamins are used in our country for degenerative lumbosacral radiculopathy, and the instructions for medical use contain a corresponding indication (radiculopathy, radicular syndromes).
Centrally acting muscle relaxants (ATC code: M03BX; tolperisone, tizanidine**, cyclobenzaprine) are recommended for degenerative lumbosacral radiculopathy (Evidence Level – 1, Recommendation Grade - B) if there are additional musculoskeletal causes of pain for which they have proven efficacy [92-94]. Currently, no superiority of any single muscle relaxant over others regarding back pain reduction has been established [92-94].
Comments. Muscle relaxants are not combined with each other. The potential sedative effect of muscle relaxants should be taken into account.
Glucocorticoids (glucocorticoids, ATC code: H02AB)** orally, intramuscularly, or intravenously are not recommended for degenerative lumbosacral radiculopathy (Evidence Level – 1, Recommendation Grade - A) because they only transiently reduce pain [67, 95] and can cause serious adverse events.
Paracetamol** (other analgesics and antipyretics, ATC code: N02B) is not recommended as a standalone treatment for degenerative lumbosacral radiculopathy (Evidence Level – 1, Recommendation Grade - A), because there is no convincing evidence of its efficacy in back pain [96, 97].
Opioids (ATC code: N02A) are not recommended for degenerative lumbosacral radiculopathy (Evidence Level – 1, Recommendation Grade - B) because their effect is short-lived [40, 67], and serious adverse events and drug dependence are possible.
Nevertheless, a number of opioids, for example, tramadol**, tapentadol**, are recommended for relief of intolerable high-intensity pain when it is impossible to do so by other means (Evidence Level – 1, Recommendation Grade - B) [41].
3.2. Surgical treatment
Discectomy using microsurgical technique, open or minimally invasive (endoscopic), is recommended for patients with dorsalgia if conservative therapy fails within 6–12 weeks (LOC – 2, GOR – A), because its superiority in reducing pain and improving functional activity in patients compared to continued conservative treatment has been proven [98-100].
Emergency surgical treatment is recommended in the early stages (the first days of the disease) in the presence of cauda equina syndrome (pelvic organ dysfunction, perineal numbness, foot weakness) (Evidence Level – 2, Recommendation Grade - B) because it reduces pain and prevents disability [2, 99, 100]. Microsurgical discectomy results in mortality less often than other spinal surgeries (less than 1 case per 1000 operations), causes the appearance or worsening of neurological deficit in 1-3%, and is accompanied by wound complications in 1-2% [101]. The reoperation rate can reach 10% [100]. The results of surgical treatment are worse if degenerative lumbosacral radiculopathy is accompanied by manifestations of depression or psychosocial distress [7]. It has not been proven that surgical treatment is more effective than conservative therapy in reducing pain and increasing functional activity in the long term (1-4 years) from the onset of the disease [99, 102, 103].
Comments. In pronounced manifestations of degenerative lumbosacral radiculopathy, microsurgical discectomy provides more effective symptom relief than conservative or minimally invasive (e.g., epidural injections) treatment methods. Patients offered surgical treatment must be informed about the risks of complications associated with the surgery and the possibility of complete recovery without surgery
3.3. Other treatment
Epidural glucocorticoid injection is recommended for patients with acute and subacute lumbosacral disc herniation (Level of Evidence – 1, Grade of Recommendation - A), because it may lead to pain reduction and improve patients' functional activity [6,7,24,104]. Epidural GC injection is advisable for significant pain intensity and in the early stages of the disease [6]. The identified adverse effects of GCs with epidural administration are minimal or absent [122, 123]. Various administration techniques are possible (caudal, transforaminal, interlaminar) [105-107]. Epidural GC injection should preferably be performed under X-ray or ultrasound guidance, which increases the accuracy of the procedure [7,106]. Epidural GC injections should be administered at no more than two nerve root levels during a single procedure and no more than 4 times a year [103,107].
Comments. The epidural GC injection procedure must be performed by a specially trained professional with appropriate skills, in a room equipped for epidural GC administration and having all the necessary supplies for emergency care in case of potential complications. The efficacy of epidural GC injection in lumbosacral disc herniation is determined not by the type of herniation, but by the degree of nerve root compression. This manipulation is less effective in cases of severe compression of root structures.
Spinal cord stimulation is recommended for patients with chronic lumbosacral disc herniation who have not achieved a positive effect from all other treatment methods, including microdiscectomy (Level of Evidence – 2, Grade of Recommendation - B), as it can reduce pain and improve patients' functional status [108-111].
The administration of various medications into the intervertebral disc is not recommended for lumbosacral disc herniation (Level of Evidence – 5, Grade of Recommendation - C), because it lacks convincing evidence of efficacy and is associated with a risk of complications [112].
4. Medical Rehabilitation and Sanatorium-Resort Treatment
Medical rehabilitation is recommended for all patients with lumbosacral disc herniation. Rehabilitation may include exercise therapy for diseases of the peripheral nervous system [45, 48, 49], manual therapy for diseases of the peripheral nervous system [51, 52, 55], pulsed low-frequency electromagnetic field therapy [64, 65] (Level of Evidence – 2, Grade of Recommendation - B), (see section "Non-pharmacological treatments").
Sanatorium-resort treatment is recommended for patients with chronic lumbosacral disc herniation and may include therapeutic mineral baths and pelotherapy (mud therapy) (Level of Evidence – 1, Grade of Recommendation - B), because these methods are effective in the comprehensive treatment of chronic back pain. They are contraindicated in concomitant oncological diseases, decreased blood clotting, cardiovascular diseases with pronounced functional disorders, and benign neoplasms prone to growth [113-116].
5. Prevention and Dispensary Observation
To prevent lumbosacral disc herniation, it is recommended to avoid excessive physical exertion (heavy lifting, carrying a heavy bag in one hand, etc.) and hypothermia (Level of Evidence – 1, Grade of Recommendation - A) — excessive physical exertion and hypothermia are identified as risk factors for back pain [117].
Patients with lumbosacral disc herniation are advised to avoid prolonged static loads (prolonged sitting, staying in an uncomfortable position, etc.) (Level of Evidence – 1, Grade of Recommendation - A), because prolonged static loads are identified as risk factors for non-specific low back pain [117].
To prevent recurrence of lumbosacral disc herniation, regular exercise therapy, therapeutic swimming in a pool, and terrain cure (walking therapy) are recommended (Level of Evidence – 1, Grade of Recommendation - A), because these treatments are proven as methods for preventing non-specific low back pain [117].
6. Organization of Medical Care
Indications for planned hospitalization:
1) Lack of effect from outpatient conservative therapy;
2) Presence of lower limb paresis;
3) Severe disability due to pain.
Indications for emergency hospitalization:
1) Suspended cauda equina compression syndrome;
2) Suspended spinal fracture;
3) Suspended spinal or spinal cord tumor;
4) Suspended inflammatory spinal disease.
Indications for patient discharge from the hospital:
1) Reduction of pain intensity according to the VAS, VRS, or NRS;
2) Reduction in the degree of functional impairment according to the Roland-Morris or Oswestry questionnaire;
3) Lack of response to treatment in the neurological department, recommendation for surgical treatment.
7. Additional Information
Obesity, smoking, depression, anxiety, catastrophizing, and sleep disorders are modifiable risk factors for chronic pain. Timely identification of these factors in patients with lumbosacral disc herniation and intervention targeting them is recommended, as it improves the prognosis for recovery and prevents subsequent exacerbations [124-126, 128-132] (Level of Evidence – 4, Grade of Recommendation - C).
Criteria for Evaluating the Quality of Medical Care
№ | Quality criteria | Performance evaluation |
|---|---|---|
1. | When collecting complaints and anamnesis in patients with suspected lumbosacral disc herniation, it is recommended to use a brief questionnaire to identify signs of so-called "specific" causes of the disease in order to select further management tactics for the patient (Table 1) | Yes/No |
2. | Pain intensity was assessed using the VAS, VRS, or NRS at the time of presentation and dynamically | Yes/No |
3. | A somatic examination was performed to check for "specific" causes of back pain | Yes/No |
4. | A clinical examination was performed with assessment of neurological status and tension signs | Yes/No |
5. | MRI or CT of the spine (one region) or radiography of the lumbosacral spine, spinal radiography with functional tests were performed when "specific" causes of back pain were suspected or other indications were present | Yes/No |
6. | The patient was informed about the benign nature of the disease and the high probability of recovery | Yes/No |
7. | High-quality rational analgesia was prescribed (according to indications: NSAIDs, centrally acting muscle relaxants, B vitamins, antiepileptic drugs, opioids, antidepressants) | Yes/No |
8. | Epidural glucocorticoid injection is recommended for patients with acute and subacute lumbosacral disc herniation | Yes/No |
9. | Neurosurgical consultation is recommended if indications are present | Yes/No |
10. | Prevention methods are recommended | Yes/No |
11. | Rehabilitation methods are recommended | Yes/No |
References
Show references
Podchufarova E.V., Yakhno N.N. Back pain. – GEOTAR-Media, 2010. 368 p.
Gushcha A.O., Konovalov N.A., Dreval O.N. et al. Clinical guidelines for the diagnosis and treatment of lumbosacral intervertebral disc herniations. Moscow: Association of Neurosurgeons of the Russian Federation; 2014. Available at: http://www.mst.ru/information/manual/lumbar_disc_herniation.pdf
Parfenov V.A., Isaykin A.I. Low back pain. – M: 2018. 200 p.
Kramer J. Intervertebral disc diseases; transl. from English; 2nd ed., edited by Prof. Shirokov V.A. MEDpress-inform. – 2015.
Khabirov F.A., Khabirova Yu.F. Neck and back pain: a guide for physicians. Kazan: Meditsina; 2014. 504 p.
Stafford M. A., Peng P., Hill D. A. Sciatica: a review of history, epidemiology, pathogenesis, and the role of epidural steroid injection in management //British journal of anaesthesia. – 2007; 99 (4):461-473.
Kreiner D. S. Hwang SW, Easa JE. et al. North American Spine Society. An evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy. Spine J. 2014 Jan;14(1):180-91.
Ropper AH, Zafonte RD. Sciatica. N Engl J Med 2015;372:1240-1248.
Deyo RA, Mirza SK Clinical practice. Herniated Lumbar Intervertebral Disk.// N Engl J Med. 2016 May 5;374(18):1763-7172.
1Fardon D. F., Williams A.l., Dohring E.G. et al. Lumbar disc nomenclature: version 2.0: Recommendations of the combined task forces of the North American Spine Society, the American Society of Spine Radiology and the American Society of Neuroradiology //The Spine Journal. – 2014;14(11): 2525-2545.
Pain syndromes. In: Neurology. National guidelines. Short edition / ed. by E.I. Gusev, A.N. Konovalov, A.B. Gekht. - M.: GEOTAR-Media, 2018. - p. 6-38.
Schroeder G. D., Guyre C. A., Vaccaro A. R. The epidemiology and pathophysiology of lumbar disc herniations //Seminars in Spine Surgery. – WB Saunders. 2016; 28(1):2-7.
Euro U., Knekt P., Rissanen H. et al. Risk factors for sciatica leading to hospitalization //European Spine Journal. – 2018;27(7):1501-1508.
Shirokov V.A., Terekhov N.L., Potaturko A.V. Impact of working conditions on the prevalence of lumbar pain syndromes (literature review). Ural Medical Journal. 2019;13(181):76-81.
Cook CE, Taylor J, Wright A, et al. Risk factors for first time incidence sciatica: a systematic review. Physiother Res Int 2014;19:65-78. 10.1002/pri.1572 24327326
Sun Z., Zhang M., Zhao XH, et al. Immune cascades in human intervertebral disc: the pros and cons. Int J Clin Exp Pathol. 2013;6:1009–1014.
Chiu CC, Chuang TY, Chang KH, et al. The probability of spontaneous regression of lumbar herniated disc: a systematic review. Clin Rehabil. 2014;29:184-195.
Davydov O.S., Yakhno N.N., Kukushkin M.L. et al. Neuropathic pain: clinical guidelines for diagnosis and treatment by the Russian Association for the Study of Pain //Russian Journal of Pain. – 2018;16 (57):5-41.
Bardin L. D., King P., Maher C. G. Diagnostic triage for low back pain: a practical approach for primary care //Medical Journal of Australia. – 2017;206(6):268-273.
Konstantinou K, Dunn KM. Sciatica: review of epidemiological studies and prevalence estimates. Spine. 2008;33(22):2464-2472.
Parfenov V.A., Yakhno N.N., Kukushkin M.L. et al. Acute non-specific (musculoskeletal) low back pain. Guidelines of the Russian Association for the Study of Pain (RASP). Neurology, Neuropsychiatry, Psychosomatics. 2018;10(2):4-11.
Parfenov V.A., Yakhno N.N., Davydov O.S. et al. Chronic non-specific (musculoskeletal) low back pain. Guidelines of the Russian Association for the Study of Pain (RASP). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(2S):7-16.
Stynes S, Konstantinou K, Ogollah R, Hay EM, Dunn KM. Clinical diagnostic model for sciatica developed in primary care patients with low back-related leg pain. PLoS One 2018;13:e0191852. 10.1371/journal.pone.0191852 29621243
Strömqvist F, Strömqvist B, Jönsson B, Karlsson MK. Surgical treatment of lumbar disc herniation in different ages-evaluation of 11,237 patients. Spine J 2017;17:1577-85. 10.1016/j.spinee.2017.03.013 28336482
Casey E. Natural history of radiculopathy //Physical Medicine and Rehabilitation Clinics. – 2011;22(1):1-5.
Konstantinou K, Dunn KM, Ogollah R, Lewis M, van der Windt D, Hay EMATLAS Study Team. Prognosis of sciatica and back-related leg pain in primary care: the ATLAS cohort. Spine J 2018;18:1030-1040.
Macki M, Hernandez-Hermann M, Bydon M, et al. Spontaneous regression of sequestrated lumbar disc herniations: Literature review. Clin Neurol Neurosurg. 2014;120:136-41.
Hooten WM, Cohen SP. Evaluation and Treatment of Low Back Pain: A Clinically Focused Review for Primary Care Specialists. Mayo Clin Proc. 2015;90(12):1699-1718.
Tsiang JT, Kinzy TG, Thompson N, Tanenbaum JE, Thakore NL, Khalaf T, Katzan IL. Sensitivity and specificity of patient-entered red flags for lower back pain. Spine J. 2019 Feb;19(2):293-300.
DePalma MG. Red flags of low back pain. JAAPA. 2020 Aug;33(8):8-11.
Premkumar A, Godfrey W, Gottschalk MB, Boden SD. Red Flags for Low Back Pain Are Not Always Really Red: A Prospective Evaluation of the Clinical Utility of Commonly Used Screening Questions for Low Back Pain. J Bone Joint Surg Am. 2018 Mar 7;100(5):368-374.
Menezes Costa LC, Maher CG, Hancock MJ et al. The prognosis of acute and persistent low-back pain: a meta-analysis. CMAJ 2012;184:E613–E24.
Genevay S, Courvoisier DS, Konstantinou K, etal . Clinical classification criteria for radicular pain caused by lumbar disc herniation: the radicular pain caused by disc herniation (RAPIDH) criteria. Spine J 2017;17:1464-1471.
Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S; European Palliative Care Research Collaborative (EPCRC). Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011 Jun;41(6):1073-93.
Mannion AF, Balagué F, Pellisé F, Cedraschi C. Pain measurement in patients with low back pain. Nat Clin Pract Rheumatol. 2007 Nov;3(11):610-8.
Ailianou A, Fitsiori A, Syrogiannopoulou A, et al. Review of the principal extra spinal pathologies causing sciatica and new MRI approaches. Br J Radiol 2012;85:672-681. 10.1259/bjr/84443179 22374280
Longo UG, Loppini M, Denaro L, Maffulli N, Denaro V. Rating scales for low back pain. Br Med Bull. 2010;94:81-144.
Brinjikji W., Luetmer PH, Comstock B et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations //American Journal of Neuroradiology. – 2015; 36(4): 811-816.
Ash LM, Modic MT, Obuchowski NA, Ross JS, Brant- Zawadzki MN, Grooff PN Effects of diagnostic information, per se, on patient outcomes in acute radiculopathy and low back pain. //AJNR Am J Neuroradiol 2008; 29(6):1098–1103
Qaseem A, Wilt TJ, McLean RM, Forciea MA Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians.// Ann Intern Med. 2017;166(7):514-530.
Mercier, F., Claret, L., Prins, K. et al. A Model-Based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-Malignant Pain. Pain Ther 3, 31–44 (2014).
Stochkendahl M. J. Kjaer P., Hartvigsen J. et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy //European Spine Journal. – 2018;27(1):60-75.
Hartvigsen J, Hancock MJ, Kongsted A, et al. What low back pain is and why we need to pay attention. Lancet 2018; 391: 2356–2367.
Urits I., Burshtein A., Sharma M. et al. Low Back Pain, a Comprehensive Review: Pathophysiology, Diagnosis, and Treatment // Current Pain and Headache Reports. 2019; 23:23
Chou R. Deyo R, Friedly J. et al. Nonpharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline //Annals of internal medicine. – 2017;166(7):493-505.
Olaya-Contreras P., Styf J., Arvidssonet D. et al. The effect of the stay active advice on physical activity and on the course of acute severe low back pain //BMC sports science, medicine and rehabilitation. – 2015;7 (1):19.
Vroomen PC, de Krom MC,Wilmink JT, Kester AD, Knottnerus JA. Lack of effectiveness of bed rest for sciatica. N Engl J Med 1999; 340(06):418–423
Fernandez M, Hartvigsen J, Ferreira ML, et al. Advice to stay active or structured exercise in the management of sciatica: a systematic review and meta-analysis. Spine (Phila Pa 1976) 2015; 40: 1457-1466.
Fernandez M, Ferreira ML, Refshauge KM, et al. Surgery or physical activity in the management of sciatica: a systematic review and meta-analysis. Eur Spine J 2016;25:3495-3512.
Machado L. A. C., Maher CG, Herbert RD et al. The effectiveness of the McKenzie method in addition to first-line care for acute low back pain: a randomized controlled trial //BMC medicine. – 2010; 8(1):10.
Santilli V, Beghi E, Finucci S. Chiropractic manipulation in the treatment of acute back pain and sciatica with disc protrusion: a randomized double-blind clinical trial of active and simulated spinal manipulations. Spine J 2006; 6: 131-7.
Rubinstein SM, van Middelkoop M, Assendelft WJJ, de Boer MR, van Tulder MW. Spinal manipulative therapy for chronic low-back pain. Cochrane Database Syst Rev 2011;(2):CD008112.
Furlan A. D., Yazdi F., Tsertsvadze A. et al. A systematic review and meta-analysis of efficacy, cost-effectiveness, and safety of selected complementary and alternative medicine for neck and low-back pain //Evidence-Based Complementary and Alternative Medicine. – 2012;2012:953139.
Bronfort G, Hondras MA, Schulz CA, Evans RL, Long CR, Grimm R. Spinal manipulation and home exercise with advice for subacute and chronic back-related leg pain: a trial with adaptive allocation. Ann Intern Med 2014; 161: 381-91.
Rubinstein SM, de Zoete A, van Middelkoop M, Assendelft WJJ, de Boer MR, van Tulder MW. Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019 Mar 13;364:l689.
Henschke N, Ostelo RW, van Tulder MW, Vlaeyen JW, Morley S, Assendelft WJ, Main CJ. Behavioural treatment for chronic low-back pain. Cochrane Database Syst Rev. 2010:CD002014.
Lamb S. E. Hansen Z, Lall R., et al. Group cognitive behavioral treatment for low-back pain in primary care: a randomized controlled trial and cost-effectiveness analysis //The Lancet. – 2010;375 (9718):916-923.
Sturgeon J. A. Psychological therapies for the management of chronic pain //Psychology research and behavior management. – 2014;7(115-124).
Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJ, Ostelo RW, Guzman J, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2014: CD000963.
Cherkin DC, Sherman KJ, Balderson BH, Cook AJ, Anderson ML, Hawkes RJ, et al. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA. 2016;315:1240-9.
Ji M, Wang X, Chen M, Shen Y, Zhang X, Yang J. The efficacy of acupuncture for the treatment of sciatica:A systematic review and meta-analysis. Evid-Based Compl Alternat Med. 2015:1–12.
Huang Z, Liu S, Zhou J, Yao Q, Liu Z. Efficacy and Safety of Acupuncture for Chronic Discogenic Sciatica, a Randomized Controlled Sham Acupuncture Trial. Pain Med. 2019 Nov 1;20(11):2303-2310.
Furlan AD, Giraldo M, Baskwill A, et al. Massage for low-back pain. Cochrane Database Syst Rev. 2015; CD001929.
Omar AS, Awadalla MA, El-Latif MA. Evaluation of pulsed electromagnetic field therapy in the management of patients with discogenic lumbar radiculopathy. Int J Rheum Dis. 2012 Oct;15(5):e101-8.
Andrade R, Duarte H, Pereira R, Lopes I, Pereira H, Rocha R, Espregueira-Mendes J. Pulsed electromagnetic field therapy effectiveness in low back pain: A systematic review of randomized controlled trials. Porto Biomed J. 2016 Nov-Dec;1(5):156-163.
Wegner I, Widyahening IS, van Tulder MW, et al. Traction for low-back pain with or without sciatica. Cochrane Database Syst Rev 2013; 8: CD003010.
Pinto RZ, Maher CG, Ferreira ML, et al. Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis. BMJ 2012;359:e49710.1136/bmj.e497.
Rasmussen-Barr E, Held U, Grooten WJ, Roelofs PD, Koes BW, van Tulder MW, Wertli MM Non-steroidal anti-inflammatory drugs for sciatica. Cochrane Database Syst Rev. 2016 Oct 15;10:CD012382.
Rasmussen-Barr E., Held U, Grooten WJ et al. Nonsteroidal anti-inflammatory drugs for sciatica: an updated Cochrane review //Spine. – 2017;42(8):586-594.
Herrmann WA, Geertsen MS. Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica/lumbosciatica: an analysis from a randomised, double-blind, multicentre, parallel-group study. Int J Clin Pract. 2009;63:1613-21.
Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008:CD000396.
Kuritzky L, Samraj GP. Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. Journal of Pain Research. 2012;5:579–90.
Karateev A.E., Nasonov E.L., Ivashkin V.T., et al. Rational use of non-steroidal anti-inflammatory drugs. Clinical guidelines. Scientific and Practical Rheumatology. 2018; 56: 1-29.
Aglas F, Fruhwald FM, Chlud K. Ergebnisse einer Anwendungsbeobachtung mit Diclofenac/Orphenadrin-Infusionen bei Patienten mit muskuloskelettalen Krankheiten und Funktionsstörungen [Results of efficacy study with diclofenac/orphenadrine infusions in patients with musculoskeletal diseases and functional disorders]. Acta Med Austriaca. 1998;25(3):86-90. German.
Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S; Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012 Dec 1;35(12):1127-46.
Castellsague J, Pisa F, Rosolen V, Drigo D, Riera-Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy. Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):365-75.
Lapeyre-Mestre M, Grolleau S, Montastruc JL; Association Française des Centres Régionaux de Pharmacovigilance (CRPV). Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002-2006. Fundam Clin Pharmacol. 2013 Apr;27(2):223-30.
Yang M, Wang HT, Zhao M, Meng WB, Ou JQ, He JH, Zou B, Lei PG. Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury. Medicine (Baltimore). 2015 Oct;94(40):e1592.
Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet. 2010 Jul 17;376(9736):173-9. doi: 10.1016/S0140-6736(10)60673-3.
Robertson K, Marshman LAG, Plummer D, Downs E Effect of Gabapentin vs Pregabalin on Pain Intensity in Adults With Chronic Sciatica: A Randomized Clinical Trial. // JAMA Neurol. 2019 Jan 1;76(1):28-34.
Mathieson S, Maher CG, McLachlan AJ, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376(12):1111-1120. doi:10.1056 /NEJMoa1614292
Hwang CJ, Lee JH, Kim JH, Min SH, Park KW, Seo HY, Song KS. Gabapentin versus Transdermal Fentanyl Matrix for the Alleviation of Chronic Neuropathic Pain of Radicular Origin: A Randomized Blind Multicentered Parallel-Group Noninferiority Trial. Pain Res Manag. 2019 Feb 4;2019:4905013.
Yildirim K., Deniz O., Gureser G. et al. Gabapentin monotherapy in patients with chronic radiculopathy: The efficacy and impact on life quality. J Back and Musculoskeletal Rehabilitation 2009;22:17–20.
Davydov O.S. Antiepileptic drugs beyond epilepsy (the use of anticonvulsants in the treatment of pain syndromes). S.S. Korsakov Journal of Neurology and Psychiatry, 2013; 4: 58-65.
Enke O., New HA, New CH et al. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis //CMAJ. – 2018;190 (26):E786-E793.
Skljarevski V, Zhang S, Desaiah D, Alaka KJ, Palacios S, Miazgowski T, et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blindtrial. J Pain. 2010;11:1282-90.
Makarov S.A., Churyukanov M.V., Churyukanov V.V. Antidepressants in pain management. Russian Journal of Pain. 2016. No. 3-4 (51). pp. 74-84
Bruggemann G., Koehler C.O., Koch E.M. Results of a double-blind study of diclofenac + vitamin B1, B6, B12 versus diclofenac in patients with acute pain of the lumbar vertebrae. A multicenter study. Klin Wochenschr. 1990; 68(2): 116-20
Mauro G. L., Martorana U., Cataldo P. et al. Vitamin B12 in low back pain: a randomised, double-blind, placebo-controlled study //European review for medical and pharmacological sciences. – 2000; 4:53-58.
Mibielli M. A., Geller M, Cohen JC, et al. Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study //Current medical research and opinion. – 2009; 25 (11): 2589-2599.
Kukushkin M.L. B vitamins (B1, B6, B12) in the combination therapy of pain syndromes. // Russian Journal of Pain. – 2019;17 (3):39-45.
van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev. 2003:CD004252
Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ. Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. Eur J Pain. 2017 Feb;21(2):228-237.
Chang WJ. Muscle Relaxants for Acute and Chronic Pain. Phys Med Rehabil Clin N Am. 2020 May;31(2):245-254.
Goldberg H, Firtch W, Tyburski M, et al. Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial. JAMA 2015; 313: 1915- 23.
Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomized controlled trial. Lancet. 2014;384:1586- 96.
Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomized placebo- controlled trials. BMJ. 2015 Mar 31; 350:h1225. doi: 10.1136/bmj.h1225
Weinstein JN, Tosteson TD, Lurie JD, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. JAMA 2006; 296: 2441-50.
Jacobs WC, van Tulder M, Arts M, et al. Surgery versus conservative management of sciatica due to a lumbar herniated disc: a systematic review. Eur Spine J 2011;20:513-22.
Clark R, Weber RP, Kahwati L. Surgical Management of Lumbar Radiculopathy: a Systematic Review. J Gen Intern Med. 2020 Mar;35(3):855-864.
Shriver MF, Xie JJ, Tye EY, et al. Lumbar microdiscectomy complication rates: a systematic review and meta-analysis. Neurosurg Focus 2015; 39(4): E6.
Osterman H, Seitsalo S, Karppinen J, Malmivaara A. Effectiveness of microdiscectomy for lumbar disc herniation: a randomized controlled trial with 2 years of follow-up. Spine 2006; 31: 2409-14
Chou R, Loeser JD, Owens DK, et al. American Pain Society Low Back Pain Guideline Panel. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society. Spine (Phila Pa 1976). 2009 May 1;34(10):1066-77.
Chou R, Hashimoto R, Friedly J, et al. Epidural corticosteroid injections for radiculopathy and spinal stenosis: a systematic review and meta-analysis. Ann Intern Med 2015; 163: 373-81.
Renfrew D. L., Moore TE, Kathol MH, et al. Correct placement of epidural steroid injections: fluoroscopic guidance and contrast administration //American journal of neuroradiology. – 1991;12 (5): 1003-1007.
Stitz M. Y., Sommer H. M. Accuracy of blind versus fluoroscopically guided caudal epidural injection //Spine. – 1999;24 (13):1371.
Ghahreman A., Ferch R., Bogduk N. The efficacy of transforaminal injection of steroids for the treatment of lumbar radicular pain //Pain Medicine. – 2010; 11 (8):1149-1168.
Kumar K., North R, Taylor R, et al. Spinal cord stimulation vs. conventional medical management: a prospective, randomized, controlled, multicenter study of patients with failed back surgery syndrome (PROCESS study) //Neuromodulation: Technology at the Neural Interface. – 2005;8(4):213-218.
North R. B. Kidd DH, Farrokhi F, Piantadosi SA. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial //Neurosurgery. – 2005;56 (1):98-107.
Kumar K., Taylor RS, Jacques L, et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation //Neurosurgery. – 2008;63 (4):762-770.
Schu S., Slotty PJ, Bara G. et al. A prospective, randomised, double‐blind, placebo‐controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome //Neuromodulation: Technology at the Neural Interface. – 2014; 17 (5): 443-450.
Zhao L., Manchikanti L. Kaye A. D. Abd-Elsayed A. Treatment of Discogenic Low Back Pain: Current Treatment Strategies and Future Options—a Literature Review// Current Pain and Headache Reports (2019) 23:86
Bai R, Li C, Xiao Y, Sharma M, Zhang F, Zhao Y. Effectiveness of spa therapy for patients with chronic low back pain: An updated systematic review and meta-analysis. Medicine (Baltimore). 2019 Sep;98(37):e17092.
Karagulle M, Karagulle MZ Effectiveness of balneotherapy and spa therapy for the treatment of chronic low back pain: a review on latest evidence // Clinical Rheumatology 2015 Feb;34(2):207-214
Roques CF, Queneau P. SPA therapy for pain of patients with chronic low back pain, knee osteoarthritis and fibromyalgia. Bull Acad Natl Med. 2016 Mar;200(3):575-86;
Tefner IK, Németh A, Lászlófi A, Kis T, Gyetvai G, Bender T. The effect of spa therapy in chronic low back pain: a randomized controlled, single-blind, follow-up study. Rheumatol Int. 2012 Oct;32(10):3163-9.
Steffens D, Maher CG, Pereira LS, et al. Prevention of Low Back Pain: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016;176(2):199-208
Kolber MR, Ton J, Thomas B, et al. PEER systematic review of randomized controlled trials: Management of chronic low back pain in primary care. Can Fam Physician. 2021 Jan;67(1):e20-e30
Urquhart DM, Wluka AE, van Tulder M, Heritier S, et al. Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Intern Med. 2018 Nov;178(11):1474-81.
Trèves R, de la Roque PM, Dumond JJ, Bertin P, et al. Prospective study of the analgesic action of clomipramine versus placebo in refractory lumbosciatica (68 cases). Rev Rhum Mal Osteoartic. 1991;58(7):549-52.
Kovarsky D, Shani A, Rod A, et al. Effectiveness of intra-venous steroids for preventing surgery for lumbo-sacral radiculopathy secondary to intervertebral disc herniation: a retrospective study of 213 patients. Sci Rep. 2022 Apr 23;12(1):6681.
Negrini F. Are epidural corticosteroid injections effective for lumbosacral radicular pain? A Cochrane Review summary with commentary. NeuroRehabilitation. 2020;47(4):509-511.
Oliveira CC, Maher CG, Ferreira ML, et al. Epidural corticosteroid injections for lumbosacral radicular pain. Cochrane Database Syst Rev. 2020 Apr 9;4(4):CD013577
Stevans JM, Delitto A, Khoja SS, et al. Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary Care. JAMA Netw Open. 2021 Feb 1;4(2):e2037371. doi: 10.1001/jamanetworkopen.2020.37371. PMID: 33591367; PMCID: PMC7887659.
Gatchel RJ, Bevers K, Licciardone JC, et al. Transitioning from Acute to Chronic Pain: An Examination of Different Trajectories of Low-Back Pain. Healthcare (Basel). 2018;6(2):48.
Chen Y, Campbell P, Strauss VY, et al. Trajectories and predictors of the long-term course of low back pain: cohort study with 5-year follow-up. PAIN. 2018;159:252–60. https://doi.org/10.1097/j.pain.0000000000001097
Zarghooni K. et al. The orthotic treatment of acute and chronic disease of the cervical and lumbar spine //Deutsches Ärzteblatt International. – 2013. – Vol. 110. – No. 44. – P. 737.
Miranda H. et al. Occupational loading, health behavior and sleep disturbance as predictors of low-back pain //Scandinavian journal of work, environment & health. – 2008. – pp. 411-419.
Nicholas M. K. et al. Early identification and management of psychological risk factors ("yellow flags") in patients with low back pain: a reappraisal // Physical Therapy. – 2011. – Vol. 91, no. 5. – P. 737-753.
Buer N., Linton S. J. Fear-avoidance beliefs and catastrophizing: occurrence and risk factor in back pain and ADL in the general population // Pain. – 2002. – Vol. 99, no. 3. – P. 485-491.
Farin E. The reciprocal effect of pain catastrophizing and satisfaction with participation in the multidisciplinary treatment of patients with chronic back pain // Health and Quality of Life Outcomes. – 2015. – Vol. 13. – P. 1-10.
Picavet H. S. J., Vlaeyen J. W. S., Schouten J. S. A. G. Pain catastrophizing and kinesiophobia: predictors of chronic low back pain // American Journal of Epidemiology. – 2002. – Vol. 156, no. 11. – P. 1028-1034.
Appendix A1. Working Group Composition
1. | Alexander V. Amelin | Professor at the Department of Neurology, Pavlov First Saint Petersburg State Medical University of the Russian Ministry of Health; Head of the Laboratory of Neurophysiology and Pharmacology of Pain, V. A. Waldman Institute of Pharmacology; Member of the Presidium of the Russian Pain Society; Doctor of Medical Sciences, Professor (Saint Petersburg). |
|---|---|---|
2. | Leila R. Akhmadeeva | Professor at the Department of Neurology, Bashkir State Medical University; Doctor of Medical Sciences, Professor (Ufa). |
3. | Evgeny E. Achkasov | Head of the Department of Physical Therapy and Sports Medicine; Professor at the Department of Hospital Surgery No. 1, Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health; Doctor of Medical Sciences, Professor (Moscow). |
4. | Evgeny R. Barantsevich | Head of the Department of Neurology and Manual Medicine, Pavlov First Saint Petersburg State Medical University; Doctor of Medical Sciences, Professor (Saint Petersburg). |
5. | Alexander E. Barulin | Head of the Department of Neurology, Psychiatry, Manual Medicine and Medical Rehabilitation, Institute of Professional Education, Volgograd State Medical University of the Russian Ministry of Health; Doctor of Medical Sciences, Professor (Volgograd). |
6. | Maxim A. Bakhtadze | Leading Researcher at the Laboratory of Fundamental and Applied Problems of Pain, Research Institute of General Pathology and Pathophysiology; Assistant Professor at the Department of Neurology, Neurosurgery and Medical Genetics, Faculty of General Medicine, Pirogov Russian National Research Medical University of the Russian Ministry of Health; Candidate of Medical Sciences (Moscow). |
7. | Anna N. Belova | Head of the Department of Medical Rehabilitation, Privolzhsky Research Medical University of the Russian Ministry of Health; Honored Doctor of the Russian Federation; Doctor of Medical Sciences, Professor (Nizhny Novgorod). |
8. | Galina N. Belskaya | Head of the Multidisciplinary Clinical and Diagnostic Center, Research Center of Neurology; Honored Doctor of the Russian Federation; Doctor of Medical Sciences, Professor (Moscow). |
9. | Vera N. Blokhina | Assistant Professor at the Department of Neurology, Institute of Advanced Training, Pirogov National Medical Research Center; Candidate of Medical Sciences (Moscow). |
10. | Vladimir G. Bychenko | Head of the Department of Diagnostic Radiology, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Russian Ministry of Health; Candidate of Medical Sciences (Moscow). |
11. | Veronika A. Golovacheva | Assistant Professor at the Department of Nervous System Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health; Candidate of Medical Sciences (Moscow). |
12. | Oleg S. Davydov | Leading Researcher at the Laboratory of Fundamental and Applied Problems of Pain, Research Institute of General Pathology and Pathophysiology; Member of the Presidium of the Russian Pain Society; Candidate of Medical Sciences (Moscow). |
13. | Olga B. Doronina | Associate Professor at the Department of Neurology, Novosibirsk State Medical University of the Russian Ministry of Health; Candidate of Medical Sciences (Novosibirsk). |
14. | Oleg N. Dreval | Head of the Department of Neurosurgery, Russian Medical Academy of Continuous Professional Education of the Russian Ministry of Health; Member of the Presidium of the Russian Pain Society; Doctor of Medical Sciences, Professor (Moscow). |
15. | Grigory Yu. Evzikov | Professor at the Department of Nervous System Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health; Doctor of Medical Sciences, Professor (Moscow). |
16. | Oleg I. Zagorulko | Head of the Clinic for the Study and Treatment of Pain, Petrovsky National Research Centre of Surgery; Member of the Presidium of the Russian Pain Society; Doctor of Medical Sciences (Moscow). |
17. | Maria A. Ivanova | Assistant Professor at the Department of Nervous System Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health; Candidate of Medical Sciences (Moscow). |
18. | Emil D. Isagulyan | Senior Researcher at the Department of Functional Neurosurgery, Burdenko National Medical Research Center of Neurosurgery of the Russian Ministry of Health; President of the National Neuromodulation Association in the Russian Federation; Candidate of Medical Sciences (Moscow). |
19. | Aleksey I. Isaykin | Associate Professor at the Department of Nervous System Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health; Candidate of Medical Sciences, Associate Professor (Moscow). |
20. | Dmitry A. Iskra | Professor at the Department of Nervous System Diseases, Kirov Military Medical Academy; Head of the North-Western Pain Society; Doctor of Medical Sciences, Professor (Saint Petersburg). |
21. | Pavel P. Kalinsky | Professor at the Institute of Clinical Neurology and Rehabilitation Medicine, Pacific State Medical University of the Russian Ministry of Health; Member of the Presidium of the Russian Pain Society; Honored Doctor of the Russian Federation; Doctor of Medical Sciences, Professor (Vladivostok). |
22. | Yulia V. Karakulova | Head of the Pervushin Department of Neurology, Academician E. A. Vagner Perm State Medical University; Chairperson of the Board of the Perm Regional Public Organization "Professional Medical Community of the Perm Krai"; Member of the Presidium of the Russian Pain Society; Doctor of Medical Sciences, Professor (Perm). |
23. | Andrey E. Karateev | Head of the Laboratory of Pain Pathophysiology and Polymorphism of Musculoskeletal Diseases, Nasonova Research Institute of Rheumatology; Member of the Presidium of the Russian Pain Society; Doctor of Medical Sciences (Moscow). |
24. | Mikhail L. Kukushkin | Head of the Laboratory of Fundamental and Applied Problems of Pain, Research Institute of General Pathology and Pathophysiology; Head of the Russian Pain Society; Doctor of Medical Sciences, Professor (Moscow). |
25. | Olga V. Kurushina | Head of the Department of Neurology, Neurosurgery and Medical Genetics, Volgograd State Medical University of the Russian Ministry of Health; Doctor of Medical Sciences, Professor (Volgograd). |
26. | Lyudmila A. Medvedeva | Chief Researcher at the Clinic for the Study and Treatment of Pain, Petrovsky National Research Centre of Surgery; Member of the Presidium of the Russian Pain Society; Doctor of Medical Sciences (Moscow). |
27. | Dina M. Merkulova | Head of the B. M. Geht Neurological Center; Chief Neurologist of the Healthcare Department of Russian Railways (RZD); Honored Doctor of the Russian Federation; Doctor of Medical Sciences, Professor (Moscow). |
28. | Vladimir A. Parfenov | Head of the Department of Nervous System Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health; Member of the Presidium of the Russian Pain Society; Doctor of Medical Sciences, Professor (Moscow). |
29. | Andrey P. Rachin | Deputy Director for Scientific Activities at the National Medical Research Center for Rehabilitation and Balneology of the Russian Ministry of Health, Board Member of the All-Russian Society of Neurologists, Professor, MD (Moscow) |
30. | Sergienko Denis Alexandrovich | Assistant Professor at the Department of Neurology, Institute of Additional Professional Education, South-Ural State Medical University of the Russian Ministry of Health (Chelyabinsk) |
31. | Strokov Igor Alekseevich | Associate Professor at the Department of Nervous System Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health; Candidate of Medical Sciences, Associate Professor (Moscow). |
32. | Habirov Farit Ahatovich | Head of the Department of Neurology at Kazan State Medical Academy — a branch of the Russian Medical Academy of Continuous Professional Education of the Russian Ministry of Health, Presidium Member of the Russian Society for the Study of Pain, Honored Scientist of the Republic of Tatarstan, Professor, MD (Kazan) |
33. | Churyukanov Maxim Valerievich | Associate Professor at the Department of Nervous System Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine at Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health, Senior Researcher at the Pain Study and Treatment Clinic of the Petrovsky National Research Center of Surgery, Presidium Member of the Russian Society for the Study of Pain, Associate Professor, PhD (Moscow) |
34. | Shirokov Vasily Afonasievich | Head of the Neurology Clinic Scientific and Production Department at the Yekaterinburg Medical Research Center for Prophylactic and Health Protection Workers in Industrial Enterprises, Professor at the Department of Nervous Diseases with a Course in Neurosurgery and Manual Therapy, Ural State Medical University of the Russian Ministry of Health, Presidium Member of the Russian Society for the Study of Pain, Professor, MD (Yekaterinburg) |
35. | Yakupov Eduard Zakirzyanovich | Head of the Department of Neurology, Neurosurgery, and Medical Genetics, Kazan State Medical University of the Russian Ministry of Health, Honored Physician of the Republic of Tatarstan, Professor, MD (Kazan) |
36. | Yakhno Nikolai Nikolayevich | President of the Russian Society for the Study of Pain, Academician of the Russian Academy of Sciences, Professor at the Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine at Sechenov First Moscow State Medical University (Sechenov University) of the Russian Ministry of Health, Professor, MD (Moscow). |
Conflict of interest: none.
Appendix A2. Methodology for Developing Clinical Guidelines
Target audience for these clinical guidelines:
Anesthesiologists-intensivists
Manual therapy physicians
Neurologists
Neurosurgeons
General practitioners (family physicians)
Osteopaths
Exercise therapy physicians
Medical rehabilitation physicians
Rheumatologists
Reflexotherapists
Internists
General practitioners / district physicians
Trauma and orthopedic surgeons
Physiotherapists
Physical and rehabilitation medicine physicians
Methods used for evidence collection/selection:
Search in electronic databases.
Description of methods used for evidence collection/selection:
The evidence base for the recommendations consists of publications included in the Cochrane Library, EMBASE, and MEDLINE databases. The search depth was 10 years.
Methods used to assess the quality and strength of evidence:
Expert consensus;
Significance assessment according to tables P1, P2, and P3.
Table P1. Levels of Evidence (LoE) grading scale for diagnostic methods (diagnostic interventions)
LoE | Definition |
|---|---|
1 | Systematic reviews of studies with reference standard control or systematic reviews of randomized controlled trials with meta-analysis |
2 | Individual studies with reference standard control or individual randomized controlled trials and systematic reviews of studies of any design, except randomized controlled trials, with meta-analysis |
3 | Studies without consecutive reference standard control or studies with a reference standard not independent of the test method, or non-randomized comparative studies, including cohort studies |
4 | Non-comparative studies, case report |
5 | Only justification of mechanism of action or expert opinion is available |
Table P2. Levels of Evidence (LoE) grading scale for prevention, treatment, and rehabilitation methods (preventive, therapeutic, and rehabilitative interventions)
LoE | Definition |
|---|---|
1 | Systematic review of randomized controlled trials with meta-analysis |
2 | Individual randomized controlled trials and systematic reviews of studies of any design, except randomized controlled trials, with meta-analysis |
3 | Non-randomized comparative studies, including cohort studies |
4 | Non-comparative studies, case reports or case series, case-control studies |
5 | Only justification of the mechanism of action of the intervention (preclinical studies) or expert opinion is available |
Table P3. Scale for grading grades of recommendation (GR) for prevention, diagnostic, treatment, and rehabilitation methods (preventive, diagnostic, therapeutic, and rehabilitative interventions)
GoR | Definition |
|---|---|
A | Strong recommendation (all considered efficacy criteria (outcomes) are important, all studies are of high or acceptable methodological quality, and their conclusions on the outcomes of interest are consistent) |
C | Conditional recommendation (not all considered efficacy criteria (outcomes) are important, not all studies are of high or acceptable methodological quality, and/or their conclusions on the outcomes of interest are inconsistent) |
C | Weak recommendation (lack of adequate quality evidence (all considered efficacy criteria (outcomes) are unimportant, all studies are of low methodological quality, and their conclusions on the outcomes of interest are inconsistent) |
Consultation and peer review:
The preliminary version was posted for broad discussion on the website of the Russian Society for the Study of Pain (www.painrussia.ru) to give the widest possible range of individuals the opportunity to participate in discussing and improving the guidelines.
Working Group:
For the final revision and quality control, the recommendations were re-evaluated by the members of the working group, who concluded that all comments and feedback from the experts had been taken into account and the risk of bias in the development of the recommendations was minimized.
Procedure for updating clinical guidelines:
The mechanism for updating clinical guidelines provides for their systematic revision at least once every 2 years.
Appendix A3. Reference Materials
These clinical guidelines were developed taking into account the following regulatory legal documents:
- Procedure for the provision of medical care to the adult population for nervous system diseases (Order of the Ministry of Health of the Russian Federation No. 926n dated November 15, 2012).
- Order of the Russian Ministry of Health No. 203n dated May 10, 2017, "On Approval of Criteria for Assessing the Quality of Medical Care"
- CG400. Chronic pain syndrome (CPS) in adult patients requiring palliative medical care.
These clinical guidelines were developed taking into account the following methodological materials and interdisciplinary specialist consensuses:
- Nasonov E.L., Yakhno N.N., Karateev A.E., et al. General principles for the treatment of musculoskeletal pain: an interdisciplinary consensus. Scientific and Practical Rheumatology. 2016;54(3):247-265.
- Karateev A.E., Nasonov E.L., Ivashkin V.T., et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Scientific and Practical Rheumatology. 2018; 56: 1-29.
- Davydov O.S., Yakhno N.N., Kukushkin M.L., Churyukanov M.V., et al. Neuropathic pain. Clinical guidelines for diagnosis and treatment. Russian Journal of Pain. 2018. No. 4 (57). P. 5-41.
These clinical guidelines were developed taking into account the indications for use, contraindications, routes of administration, and doses of medicinal products in accordance with the instructions for medical use contained in the State Register of Medicinal Products — www.grls.rosminzdrav.ru
Appendix B. Physician Action Algorithms

Appendix C. Patient Information
Discogenic lumbosacral radiculopathy is a medical term describing pain and neurological disorders caused by spinal nerve root damage ("pinched nerve").
However, it is important to know that disc herniations are very common in people without any complaints and do not require special treatment. The diagnosis of radiculopathy is established by a physician based on complaints (back pain radiating to the leg), detection of sensory and motor deficits, and reflex changes.
When to see a doctor?
If you develop back pain radiating to the leg, accompanied by numbness, tingling, or limb muscle weakness.
If this is accompanied by urination disorders (urinary retention or incontinence), defecation disorders, or perineal numbness, you should consult a doctor immediately!
Are additional diagnostic tests necessary?
Consultation with a physician involving a history-taking, evaluation of complaints, somatic status, and nervous system status makes it possible to establish a diagnosis and prescribe treatment without instrumental and laboratory tests. If the physician detects signs of another disease during the examination, they will prescribe the necessary diagnostic methods.
Magnetic resonance imaging (MRI) is most commonly used to detect disc herniation. If you have contraindications to MRI (e.g., metal objects in the body, a pacemaker), X-ray computed tomography can be used. Routine radiography does not allow for the diagnosis of disc herniation.
How is radiculopathy treated?
Discogenic lumbosacral radiculopathy has a favorable prognosis due to the gradual reduction of the disc herniation and associated non-infectious inflammatory changes. In most cases, pain decreases and working capacity is restored within a few weeks.
It is very important to maintain daily activity as much as possible because it promotes faster recovery; conversely, prolonged (more than 3–5 days) bed rest delays recovery. It is essential to learn the correct technique for performing certain movements (e.g., lifting objects from the floor) and exercises to optimize muscle condition, as demonstrated by exercise therapy (rehabilitation) physicians.
To reduce pain, the doctor may prescribe nonsteroidal anti-inflammatory drugs (by prescription). If their effect is insufficient, they can be supplemented with more potent medications (by prescription).
If even this is insufficient, painkillers can be injected into the area of spinal nerve root compression; this procedure is performed only in specialized centers by qualified specialists who have undergone appropriate training.
Is surgery necessary?
In rare cases, when urination and defecation disorders and leg weakness occur, emergency surgery is required. In most cases, surgical treatment is considered if pain does not decrease and working capacity is not restored within 6–12 weeks. In such cases, a neurosurgeon consultation is necessary to assess the need for surgery. Surgery allows for the removal of the disc herniation, "freezing" (freezing -> releasing) the nerve root. The scope of surgery, as well as its risks, is determined individually, depending on the severity of symptoms, the location of the herniation, and overall health status. Surgical treatment allows for faster pain relief and restoration of working capacity compared to continuing conservative treatment. However, over a long-term period (1 year or more from the onset of the disease), there are no significant differences between individuals who underwent surgical treatment and those who continued conservative treatment.
Appendix G. Assessment Scales, Questionnaires, and Other Evaluation Tools
Appendix G 1. Symptoms of lumbar and sacral nerve root involvement

Appendix G 2. Pain Intensity Rating Scales
Russian name: visual analog scale (VAS), numeric rating scale (NRS), verbal rating scale (VRS)
Original name: Visual Analog Scale, Numeric Rating Scale, Verbal Rating Scale
Sources:
A.Williamson, B. Hoggart: Pain: a review of three commonly used pain rating scales. Journal of Clinical Nursing. 14:798-804 2005.
Pain: A guide for students and physicians : textbook / ed. by RAMS Academician N.N. Yakhno. — M. : MEDpress-inform, 2010. — 304 p.
Type – scale
Purpose: assessment of pain intensity
Explanation: The VAS is a 10 cm (100 mm) line on which the patient is asked to make a mark corresponding to the intensity of pain experienced at the moment (or over a certain period, e.g., the last week), with the patient choosing between "no pain" and "unbearable pain". Then, the distance between the start of the scale ("no pain") and the patient's mark is measured with a ruler, and centimeters are then converted into points (1 cm = 10 mm = 1 point).
The NRS is similar to the VAS and is a modification of it. The patient marks one of 11 (sometimes a gradation from 0 to 10 is used) points on the scale corresponding to the current intensity of their pain.
The VRS consists of adjectives describing pain, arranged in order of increasing intensity. Sometimes a scale containing both adjectives and numerical designations is used (0 – "no pain", 1 – "mild", 2 – "moderate", 3 – "severe", 4 – "very severe", 5 – "unbearable"). The algorithm of use is the same as for the VAS.

Appendix G 3. Clinical Examination with Neurological Status Assessment
Assessment of somatic status in patients with discogenic lumbosacral radiculopathy is carried out according to generally accepted standards; they are aimed at identifying a specific disease (tumor, trauma, infection, or other condition) that may manifest as back pain.
It is recommended to observe the patient while undressing, assessing the restriction of movement in the lumbar spine. Inspection from the back evaluates the presence of lateral curvature (scoliosis). Inspection from the side notes an increase or decrease in physiological lumbar lordosis or thoracic kyphosis. It is recommended to assess hypotrophy and (or) asymmetry of the shoulder girdle muscles of the upper extremities, pelvic muscles, and lower extremities. It is recommended to ask the patient to walk in one direction on their toes and return on their heels, and (or) stand on their toes or heels. Difficulty walking (standing) on the toes indicates a possible lesion of the first sacral root; difficulty walking (standing) on the heel indicates a possible lesion of the fifth lumbar root.
It is recommended to palpate the spinous and transverse processes, and the attachment sites of muscles and tendons to bony prominences. In the lumbar region, lateral flexion and forward flexion (touching the floor with hands) are assessed, provided this does not cause pain.
It is recommended to assess pain sensitivity and the strength of various muscles of the lower extremities, evaluate the knee and Achilles reflexes, and, if a lesion of the first, second, and third lumbar roots is suspected, the cremasteric and adductor reflexes.
It is recommended to perform the Lasegue test. The appearance or significant intensification of pain when raising the straightened leg at an angle of 30° to 70° in a supine patient (Lasegue's sign), followed by its disappearance or reduction when the leg is bent at the knee joint, is characteristic of radiculopathy of the fifth lumbar and first sacral roots. If pain appears when raising the leg at an angle between 30° and 70°, dorsiflexion of the foot usually increases the pain in discogenic radiculopathy (Bragard's sign). If pain appears when raising the leg more than 70°, this is not regarded as pathology (observed in the majority of healthy individuals). Discogenic radiculopathy is characterized by the appearance (intensification) of pain on the affected side when raising the "healthy" leg (crossed Lasegue's sign), but this is a less sensitive test.
The Wasserman and Mauthner tests are also of diagnostic value. Wasserman's sign — the appearance of pain along the anterior surface of the thigh when lifting the straightened leg upward in a patient lying on their stomach — indicates the possibility of upper and middle lumbar root involvement. Mauthner's sign — the appearance of pain alongடைய the anterior surface of the thigh when flexing the lower leg in a patient lying on their stomach — indicates the possibility of lower lumbar root involvement.
It is recommended to perform Bonnet's test, the Bonnet-Bobrovnikova test (reproduction of pain during passive hip adduction with simultaneous internal rotation in a supine patient) for differential diagnosis with piriformis syndrome of the sciatic nerve, and Patrick's test (limitation and pain in the projection of the sacroiliac joint during passive external rotation of the hip with the leg bent at the knee and hip joints (heel touching the knee area of the other straightened leg)) for differential diagnosis with coxarthrosis and sacroiliac joint pathology.
Comments. "Tension" tests indicate damage to the lumbar and sacral roots, but do not allow determining the lesion of a specific root. Based solely on a neurological examination, it is difficult to differentiate between radiculopathy and lumbosacral plexus lesions in patients without a clear clinical picture of radicular pain syndrome.
Appendix G 4. Muscle Strength Grading Scale
Russian title: Medical Research Council (MRC) Muscle Strength Scale
Original title: Medical Research Council (MRC) Weakness Scale
Sources:
Medical Research Council. Aids to the examination of the peripheral nervous system, Memorandum no. 45, Her Majesty’s Stationery Office, London, 1981.
https://mrc.ukri.org/research/facilities-and-resources-for-researchers/mrc-scales/mrc-muscle-scale/
van der Ploeg RJ, Osterhuis HJ, Reuvekamp J. Measuring muscle strength. J Neurol. 1984;231(4):200‐203.
A.N. Belova. Scales, Tests, and Questionnaires in Neurology and Neurosurgery. Moscow: Prakticheskaya Meditsina, 2018. — 696 p.
Type – rating scale
Purpose: assessment of muscle strength in points
Score | Muscle strength assessment |
|---|---|
5 | Normal strength |
4 | Reduction of strength against active resistance while maintaining the ability to perform movements overcoming the limb's own weight |
3 | Inability to perform movements that overcome the limb's own weight |
2 | Muscle contracts, but no limb movement occurs |
1 | Only muscle fibrillations are present |
0 | Complete absence of muscle activity |
Explanation: a six-point scale (from 5 to 0) is used to assess the strength of individual muscles and muscle groups. A comparative assessment of the affected and healthy sides is performed. A score of 5 indicates no paresis. Paresis is defined as mild if strength corresponds to 4 points, moderate to 3 points, pronounced to 2 points, severe to 1 point, and paralysis to 0 points. It can be used dynamically; the modified scale allows calculating the ratio of muscle strength between the healthy and affected sides as a percentage.
Appendix G 5. Oswestry Disability Index
Russian title: Oswestry Questionnaire
Original title: The Oswestry low back pain disability questionnaire.
Sources:
Fairbank J.C., Couper J., Davies J.B., et al. The Oswestry low back pain disability questionnaire // Physiotherapy. 1980. Vol. 66. P. 271–273.
Bakhtadze M.A., Bolotov D.A., Kuzminov K.O. Low back pain disability index (Oswestry questionnaire): assessment of reliability and validity of the Russian version. Manualnaya Terapiya, 2016.-N 4.-P.24-33.
Cherepanov V.A. The Russian version of the Oswestry questionnaire: cultural adaptation and validity. Hirurgia Pozvonochnika 2009;(3):93–98.
Type – questionnaire
Purpose: Assessment of the degree of functional impairment (disability) in chronic lower back pain
This questionnaire is designed to obtain information on how back or leg pain has affected your daily life | |
|---|---|
Please answer every section and mark in each section only one box which applies to you. | |
We understand that you may consider that two statements in any one section relate to you, but please just mark the box that most closely describes your problem. | |
Section 1. Pain intensity. | |
| |
| |
| |
| |
| |
| |
Section 2. Personal care (washing, dressing, etc.) | |
| |
| |
| |
| |
| |
| |
Section 3. Lifting. | |
| |
| |
| |
| |
| |
| |
Section 4. Walking. | |
| |
| |
| |
| |
| |
| |
Section 5. Sitting. | |
| |
| |
| |
| |
| |
| |
Section 6. Standing. | |
| |
| |
| |
| |
| |
| |
Section 7. Sleeping. | |
| |
| |
| |
| |
| |
| |
Section 8. Sex life. | |
| |
| |
| |
| |
| |
| |
Section 9. Social life. | |
| |
| |
| |
| |
| |
| |
Section 10. Traveling. | |
| |
| |
| |
| |
| |
|
Explanation: The Oswestry questionnaire consists of 10 sections. In each section, the first answer is the minimum score (0), and subsequent answers are 1, 2, 3, 4, and 5 points, respectively. When all 10 sections are completed, the Oswestry index is calculated as follows: sum of scores / 50 (maximum possible score) × 100 =. If one of the sections is not filled out or cannot be assessed (e.g., sex life), the Oswestry index is calculated as follows: sum of scores / 45 (maximum possible score) × 100 =. The higher the index, the more significant the disability. The questionnaire can also be used to assess the patient's condition dynamically, for example, during therapy.
Appendix G 6. Roland-Morris Disability Questionnaire
Russian title: Roland-Morris Questionnaire
Original title: Roland-Morris Disability Questionnaire, RDQ
Sources:
Roland M.O., Morris R.W. A study of the natural history of back pain. Part 1: Development of a reliable and sensitive measure of disability in low back pain //Spine. – 1983. – Vol. 8. – P. 141–144.
Tarakanov A.A., Efremov V.V. Instrumental validation of the "Low Back Pain and Disability (Roland-Morris)" questionnaire. Russian Journal of Pain: 2 (56); 2018. pp. 96-97.
Type – questionnaire
Purpose: assessment of the impact of lower back pain on disability.
Check only those statements that describe your condition today.
Because of my back, I stay at home most of the time. | |
|---|---|
I change position frequently to try and get my back comfortable. | |
Because of my back, I walk more slowly than usual. | |
Because of my back, I am not doing any jobs that I usually do around the house. | |
Because of my back, I use a handrail to get upstairs. | |
Because of my back, I lie down to rest more often. | |
Because of my back, I have to hold on to something to get out of an easy chair. | |
Because of my back, I try to get other people to do things for me. | |
Because of my back, I get dressed more slowly than usual. | |
Because of my back, I can only stand for short periods of time. | |
Because of my back, I try not to bend or kneel down. | |
Because of my back, it is painful to get out of a chair. | |
My back is painful almost all the time. | |
Because of my back, I find it difficult to turn over in bed. | |
Because of my back pain, I am not enjoying my food as much as usual. | |
Because of my back pain, I have trouble putting on socks (stockings). | |
Because of my back, I can only walk a short distance. | |
I sleep less well because of my back. | |
Because of my back pain, I have to get dressed with help from someone else. | |
Because of my back, I sit down almost all day. | |
Because of my back, I avoid heavy housework. | |
Because of my back pain, I am more irritable and short-tempered with other people than usual. | |
Because of my back, I walk up stairs slower than usual. | |
Because of my back, I lie in bed almost all day. |
Note: The Roland-Morris questionnaire consists of 24 items answered by the patient. The total number of items checked by the patient is calculated, yielding a possible score from 0 to 24. The higher the number of checked items, the greater the impairment in the patient's daily functioning. To monitor treatment dynamics, the questionnaire can be completed again, and the number of items showing improvement can be converted into a percentage.